Anatara Lifesciences Ltd

ANR

Company Profile

  • Business description

    Anatara Lifesciences Ltd is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Its products include the Gastrointestinal ReProgramming dietary supplement (GaRP) for humans and Detach for animals. It generates its income from license revenue.

  • Contact

    c/- Perks, 81 Flinders Street
    Level 8
    AdelaideSA5000
    AUS

    T: +61 438027172

    https://www.anataralifesciences.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2025

    Employees

Stocks News & Analysis

stocks

ASX shares plunge but remain undervalued

Shares drop 17% after guidance is revised but we still see value.
stocks

Ask the analyst: Why have markets shunned APA Group?

Australia's premier gas infrastructure firm used to be a market darling, but its shares have taken a severe de-rating in recent years.
stocks

The 10 best US dividend stocks

These undervalued stocks with reliable dividends are worth considering.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,577.8021.60-0.25%
CAC 407,490.2837.860.51%
DAX 4020,317.1012.84-0.06%
Dow JONES (US)42,635.20106.840.25%
FTSE 1008,319.6968.660.83%
HKSE19,240.8938.95-0.20%
NASDAQ19,478.8810.80-0.06%
Nikkei 22539,605.09375.97-0.94%
NZX 50 Index12,931.2112.53-0.10%
S&P 5005,918.259.220.16%
S&P/ASX 2008,329.2019.90-0.24%
SSE Composite Index3,211.3918.77-0.58%

Market Movers